JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 96 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $228,648,000 | 42.85% |
| Pharmstandard International S.A. | 662,063 | $14,797,000 | 37.17% |
| TRV GP III, LLC | 3,048,780 | $68,140,000 | 24.53% |
| Omega Fund Management, LLC | 529,965 | $11,845,000 | 11.64% |
| Casdin Capital, LLC | 635,000 | $14,192,000 | 2.50% |
| Virtus ETF Advisers LLC | 58,867 | $1,316,000 | 1.14% |
| Redmile Group, LLC | 1,182,393 | $26,426,000 | 1.02% |
| PFM Health Sciences, LP | 1,923,651 | $42,994,000 | 0.87% |
| Elephas Investment Management Ltd | 154,400 | $3,451,000 | 0.63% |
| Ghost Tree Capital, LLC | 125,092 | $2,796,000 | 0.57% |